The Latest Cardiac and Vascular News
Company announces positive first-in-human study results, the close of a $6.9 million Series A financing, and FDA approval of its Investigational Device Exemption. ST. LOUIS, Oct. 9, 2025 /PRNewswire/ — Amplifi Vascular, developer of the first-of-its-kind Vein Dilation System designed to…
BOERNE, Texas, Oct. 8, 2025 /PRNewswire/ — Building once again on their first mover position as a leader in endovascular hemorrhage control and resuscitation, Prytime Medical Devices, Inc. (Prytime) this week announced a new FDA 510(k) clearance for their flagship pREBOA-PRO™ Catheter….
New larger diameters broaden treatment options for physicians managing complex peripheral artery disease WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular, a leader in innovative endovascular technologies, today announced the commercial launch of the Serranator® PTA Serration Balloon Catheter in 7.0 mm and 8.0 mm diameters. This expansion brings the proven benefits of serration […]
Groundbreaking remotely operable robotic system to transform intervention for stroke and cardiovascular disease, while radically expanding access to care for patients around the world. SAN FRANCISCO, Oct. 6, 2025 /PRNewswire/ — Remedy Robotics, Inc., a leading medical technology company,…
Renowned endovascular specialists from Columbia and Stanford to guide pivotal trial of Artero™ electric IVL system. MINNEAPOLIS, Sept. 30, 2025 /PRNewswire/ — FastWave Medical, a pioneering intravascular lithotripsy (IVL) startup, today announced the appointment of its principal…
Santreva-ATK is the world’s first wire-free, external power-free, intraplaque chronic total occlusion (CTO) crossing and one-step vessel preparation platform for femoropopliteal arteries. – Atheroplasty represents a new era in endovascular revascularization of complex lesions in severely stenosed vessels, including CTOs – Now available in Europe; U.S. launch planned for October […]
New global HQ features over 37,000 square feet that includes R&D and manufacturing BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, announced today the opening of its new global headquarters at 180 Third Avenue in Waltham, Mass. The new 37,811 […]
Livestream Interview Can be Viewed on September 24th at 10:45am ET at Benzinga All Access Live Livestream Interview Can be Viewed on September 24th at 10:45am ET at Benzinga All Access Live
Jupiter Endovascular’s Vertex™ Catheter just received 510(k) clearance for the insertion of endovascular devices. This technology adopts Transforming Fixation (TFX) — able to shift from flexible to firm on demand, giving physicians true stability and control. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K252027
SYMPHONY-PE Trial Demonstrated Strong Efficacy, Efficiency, and Safety Results with No Mortality and No Device-Related Serious Adverse Events CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced positive efficacy and safety results from the pivotal SYMPHONY-PE Trial (NCT06062329) evaluating the company’s Symphony® Thrombectomy System in the treatment of acute pulmonary embolism (PE). Results […]
